| http://www.w3.org/ns/prov#value | - From 1990 onwards, the main issue to be decided was how far an agreement on intellectual property would deviate from the blueprint that had been provided to negotiators in 1988 by Pfizer, IBM, DuPont and other members of the international business community.
|
